Facilitating the research of numerous nationally and internationally recognized scientists, in over sixty labs across British Columbia, to improve cancer care.

BC Cancer Research strives to improve the lives of patients through the integration of basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, population health, and the development of innovative new technology, programs, and interventions. Organized through departments and programs with various themes, BC Cancer supports groundbreaking cancer research and personalized care approaches through world-class facilities and platforms including genomics, bioinformatics, imaging, drug development and tissue banking.

Our Research

The success of BC Cancer is driven by the people and their passion to reduce the impact of cancer on people and society. Our 2022 Research Report showcases how BC Cancer continues to be internationally recognized for our excellence in cancer research and its integrated model of cancer planning and care. 

Read the 2022 BC Cancer Research Report

News & Events

Dr. Zhenwei Ma receives Banting Postdoctoral Fellowship

Congratulations to Dr. Zhenwei Ma of Gao Lab (Integrative Oncology) for receiving a Banting Postdoctoral Fellowship. 

The award is tied to the project titled, "Hydrogel adhesive artificial mucosa: a paradigm-shifting platform for esophageal cancer treatment and management.”

The Banting Postdoctoral Fellowships program provides funding to the very best postdoctoral applicants, both nationally and internationally, who will positively contribute to the country's economic, social, and research-based growth. 

First systemic therapy patient enrolled in a clinical trial in Prince George

BC Cancer – Prince George celebrated a significant milestone in early 2024 with the opening of a new clinical trial called CIRCULATE-NORTH-AMERICA, or CRC10, which marked the first time a systemic therapy clinical trial has been offered in northern B.C. to people with cancer. Since opening CRC10 in January 2024, the team in Prince George has enrolled two patients in this study.

Research Recovery Resources

BC Cancer Research is taking a gradual and careful approach to re-opening research activities to protect our staff, patients and communities.

Access our COVID-19 recovery resources.

Our Strategic Plan

Our Strategic Plan outlines our direction to strengthen our research capabilities and collaboration with departments and partners to improve our ability to generate knowledge, enhance the impact of our research, and support innovation in clinical care.  

Read the BC Cancer Research Strategic Plan.


Evaluation of Homologous Recombination Deficiency Signatures in Advanced Gastrointestinal and Thoracic Cancers Reveals Correlation with Platinum Therapy Duration

NPJ Precis Oncology
Erica S Tsang, Veronika Csizmok, Laura M Williamson, Erin Pleasance, James T Topham, Joanna M Karasinska, Emma Titmuss, Intan Schrader, Stephen Yip, Basile Tessier-Cloutier, Karen Mungall, Tony Ng, Sophie Sun, Howard J Lim, Jonathan M Loree, Janessa Laskin, Marco A Marra, Steven J M Jones, David F Schaeffer, Daniel J Renouf
Back to top